• SENSEX
    NIFTY 50
Business

GSK to launch late-stage testing of syncytial virus vaccine

Updated : October 21, 2020 11:12 AM IST

GSK said Phase III studies, with the potential to produce data for regulatory approval, would likely start over the coming months. 
The vaccines were well-tolerated with side effects including injection-site pain and headache, GSK added.
GSK to launch late-stage testing of syncytial virus vaccine

You May Also Like

Live TV

recommended for you

Advertisement